Latest News about Abbott Laboratories
Recent news which mentions Abbott Laboratories
Jim Cramer's hopeful on Abbott Labs after court case win
November 01, 2024
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
From CNBC.com News
Cramer's week ahead: Major banks, Taiwan Semi and Netflix report as earnings season gets into full swing
October 11, 2024
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
From CNBC.com News
Abbott launches its first over-the-counter continuous glucose monitor in the U.S.
September 05, 2024
From CNBC.com News
Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's like
August 26, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Tickers
JOBS
From CNBC.com News
Cramer's Lightning Round: Cummins is a buy
April 11, 2024
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
February 20, 2024
From CNBC.com News
Companies can now help workers pay off student debt while saving for retirement—these 3 already offer the benefit
February 06, 2024
From CNBC.com News
From CNBC.com News
Cramer lists his major themes for the market in 2024
January 17, 2024
From CNBC.com News
From CNBC.com News
Cramer says today's market is more interested in AI technology for advertising, not health-care solutions
January 09, 2024
From CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
From CNBC.com News
Investor Michael Farr is back with his top 10 stocks he's buying for 2024, and the tilt is defensive
December 28, 2023
From CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
From CNBC.com News
Starting January, making student loan payments can benefit your retirement savings. Here's how
December 09, 2023
Tickers
CEOS
From CNBC.com News
From CNBC.com News
Cramer's Lightning Round: 'Stay away' from Catalent
November 29, 2023
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
From CNBC.com News
From CNBC.com News
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
From CNBC.com News
Cramer's Lightning Round: 'I'm moving on' from Herbalife
October 10, 2023
From CNBC.com News
As Covid testing business drops, Abbott searches for new line of business with consumer wearables
October 10, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.